Synergistic Biocidal Composition for Chronic Wound Biofilm Elimination

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current wound cleansers fail to effectively eliminate microbial biofilms in chronic and acute wounds, leading to prolonged healing times and increased medical costs, as they often result in partial reduction with potential regrowth of biofilms.

Innovation Solution

An antimicrobial composition combining a polymeric biguanide with a vicinal diol, such as monoalkyl glycol, monoalkyl glycerol, or monoacyl glycerol, which synergistically reduces or eliminates biofilms by 4 log orders within 10 minutes with no regrowth within 24 hours, enhancing wound healing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current wound cleansers are used, then wound cleaning is performed, but biofilm elimination is insufficient leading to regrowth

Engineering Contradiction:
Improvebiofilm elimination effectivenessVSAvoidhealing time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent changes the chemical parameters of the wound cleanser by incorporating specific biocidal agents (polymeric biguanides, vicinal diols, and their combinations) at optimized concentrations. This chemical parameter change enables complete biofilm elimination rather than partial reduction, directly resolving the contradiction between cleaning effectiveness and healing time

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses composite antimicrobial formulations combining multiple active ingredients (polymeric biguanides with vicinal diols, or quaternary ammonium compounds with vicinal diols) synergistically. This composite approach enhances biofilm penetration and elimination capability, achieving complete biofilm eradication and preventing regrowth, thus reducing overall healing time

Inventive Principle:
Principle #40Composite materials

2Reliability

If frequent debridement is performed to eliminate biofilm, then biofilm burden is reduced, but patient trauma and medical costs increase

Engineering Contradiction:
Improvebiofilm elimination effectivenessVSAvoidpatient trauma
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the mechanical debridement process with a chemical-biocidal system. The biocidal agents (polymeric biguanides, vicinal diols, or quaternary ammonium compounds) chemically penetrate and eliminate biofilms without requiring physical removal, thereby achieving complete biofilm eradication while avoiding patient trauma associated with frequent surgical debridement

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If multiple simultaneous strategies are used to suppress biofilm, then wound healing is enhanced, but treatment complexity increases

Engineering Contradiction:
Improvewound healing effectivenessVSAvoidtreatment protocol complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges multiple biocidal mechanisms into a single integrated formulation. By combining polymeric biguanides with vicinal diols, or quaternary ammonium compounds with vicinal diols, the formulation achieves synergistic biofilm elimination, complete eradication, and regrowth prevention in one treatment, simplifying the overall treatment protocol while maintaining high healing effectiveness

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The antimicrobial composition achieves complete biofilm elimination and rapid wound healing by utilizing a synergistic interaction between polymeric biguanides and vicinal diols, reducing microbial load and preventing regrowth, thereby reducing patient suffering and medical costs.

Implementation Method 1

An antimicrobial composition comprising at least one polymeric biguanide and at least one antimicrobial vicinal diol

Methodology Applied
Scientific EffectSynergistic interaction:

Implementation Method 2

The antimicrobial composition achieves complete biofilm elimination and rapid wound healing by utilizing a synergistic interaction between polymeric biguanides and vicinal diols, reducing microbial load and preventing regrowth

Methodology Applied
Scientific EffectBiofilm elimination:

Data Source

PatentEP2787985B1Biocidal compositions and methods of using the same
Publication Date: 2020.07.01 ROCHAL IND LLC
  • EP2787985B1 patent drawingFigure 1~2
  • EP2787985B1 patent drawingFigure 3~4
  • EP2787985B1 patent drawingFigure 5

AI summary

An antimicrobial composition with synergistic biocidal activity is described which comprises at least one antimicrobial polymeric biguanide and at least one antimicrobial vicinal diol, said vicinal diol comprises at least one monoalkyl glycol, monoalkyl glycerol, or monoacyl glycerol, to diminish or eliminate biofilm communities. Such synergistic interaction is effective in wound treatment, particularly for chronic wounds, burns and battlefield-induced wounds, as well as for disinfecting non-biological surfaces. The antimicrobial composition can also be prepared as viscous solutions or as gels. The antimicrobial composition may be added to a substrate and dried, such as to a catheter, or to a foam, or to a fiber wound dressing, or coated as a viscous solution or gel upon such devices, to provide controlled release antimicrobial activity.